Supernus Pharmaceuticals Stock Target Price
| SUPN Stock | USD 28.04 0.01 0.04% |
Supernus Pharmaceuticals fundamentals help investors to digest information that contributes to Supernus Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Supernus Stock. The fundamental analysis module provides a way to measure Supernus Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Supernus Pharmaceuticals stock.
Supernus | Target Price |
Supernus Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Supernus Pharmaceuticals' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Supernus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Supernus Pharmaceuticals by comparing valuation metrics of similar companies.Supernus Pharmaceuticals is currently under evaluation in target price category among related companies.
Supernus Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Supernus Pharmaceuticals from analyzing Supernus Pharmaceuticals' financial statements. These drivers represent accounts that assess Supernus Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Supernus Pharmaceuticals' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.2B | 1.3B | 1.5B | 1.9B | 1.6B | 1.7B | |
| Enterprise Value | 1.4B | 1.4B | 1.8B | 2.3B | 1.5B | 1.6B |
Supernus Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Supernus Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Supernus Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Supernus Fundamentals
| Return On Equity | -0.0168 | ||||
| Return On Asset | 0.0023 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 54.97 M | ||||
| Shares Owned By Insiders | 5.02 % | ||||
| Shares Owned By Institutions | 94.98 % | ||||
| Number Of Shares Shorted | 4.82 M | ||||
| Price To Earning | 15.25 X | ||||
| Price To Book | 1.80 X | ||||
| Price To Sales | 2.72 X | ||||
| Revenue | 607.52 M | ||||
| Gross Profit | 580.02 M | ||||
| EBITDA | 98.26 M | ||||
| Net Income | 1.32 M | ||||
| Cash And Equivalents | 360.79 M | ||||
| Cash Per Share | 6.74 X | ||||
| Total Debt | 41.53 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 0.85 X | ||||
| Book Value Per Share | 16.91 X | ||||
| Cash Flow From Operations | 111.08 M | ||||
| Short Ratio | 14.05 X | ||||
| Earnings Per Share | (0.28) X | ||||
| Price To Earnings To Growth | 1.47 X | ||||
| Target Price | 40.5 | ||||
| Number Of Employees | 652 | ||||
| Beta | 1.01 | ||||
| Market Capitalization | 1.58 B | ||||
| Total Asset | 1.41 B | ||||
| Retained Earnings | 482.56 M | ||||
| Working Capital | 202.92 M | ||||
| Current Asset | 105.95 M | ||||
| Current Liabilities | 56.93 M | ||||
| Net Asset | 1.41 B |
About Supernus Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Supernus Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Supernus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Supernus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Supernus Pharmaceuticals Piotroski F Score and Supernus Pharmaceuticals Altman Z Score analysis. To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Supernus Stock analysis
When running Supernus Pharmaceuticals' price analysis, check to measure Supernus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Supernus Pharmaceuticals is operating at the current time. Most of Supernus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Supernus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Supernus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Supernus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Supernus Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Supernus Pharmaceuticals. If investors know Supernus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Supernus Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (0.28) | Revenue Per Share 10.933 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0023 |
The market value of Supernus Pharmaceuticals is measured differently than its book value, which is the value of Supernus that is recorded on the company's balance sheet. Investors also form their own opinion of Supernus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Supernus Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Supernus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Supernus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Supernus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Supernus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Supernus Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.